Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Dawnrays Pharmaceutical (Holdings) Ltd. has announced the resignation of its CEO, Mr. Wu Weixian, effective from 5:00 pm on 11 September 2024, due to his desire to focus on personal commitments. The company is actively seeking a replacement and will update shareholders and the Hong Kong Stock Exchange once a suitable candidate is found. The board extends its gratitude to Mr. Wu for his services during his tenure.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.